Cornerstone Wealth Management LLC boosted its position in shares of Clorox Co (NYSE:CLX) by 4.9% during the 3rd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 14,699 shares of the company’s stock after purchasing an additional 680 shares during the period. Cornerstone Wealth Management LLC’s holdings in Clorox were worth $115,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Livingston Group Asset Management CO operating as Southport Capital Management purchased a new position in Clorox during the 3rd quarter worth approximately $130,000. Fort L.P. purchased a new position in Clorox during the 2nd quarter worth approximately $129,000. Legacy Advisors LLC purchased a new position in Clorox during the 3rd quarter worth approximately $150,000. IMS Capital Management purchased a new position in Clorox during the 2nd quarter worth approximately $161,000. Finally, Successful Portfolios LLC purchased a new position in Clorox during the 3rd quarter worth approximately $206,000. Hedge funds and other institutional investors own 78.35% of the company’s stock.

Clorox stock opened at $158.77 on Friday. The company has a debt-to-equity ratio of 3.38, a quick ratio of 0.65 and a current ratio of 1.07. Clorox Co has a 12 month low of $113.57 and a 12 month high of $159.17. The firm has a market cap of $20.14 billion, a PE ratio of 26.83, a P/E/G ratio of 3.87 and a beta of 0.28.

Clorox (NYSE:CLX) last posted its quarterly earnings results on Wednesday, October 31st. The company reported $1.62 EPS for the quarter, beating the consensus estimate of $1.59 by $0.03. Clorox had a net margin of 13.59% and a return on equity of 102.65%. The business had revenue of $1.56 billion for the quarter, compared to analysts’ expectations of $1.53 billion. During the same period in the previous year, the company posted $1.46 EPS. Clorox’s revenue was up 4.2% on a year-over-year basis. As a group, equities analysts expect that Clorox Co will post 6.31 earnings per share for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, November 16th. Investors of record on Wednesday, October 31st will be paid a $0.96 dividend. This represents a $3.84 annualized dividend and a dividend yield of 2.42%. The ex-dividend date is Tuesday, October 30th. Clorox’s payout ratio is presently 61.34%.

In related news, COO Dawn C. Willoughby sold 54,205 shares of Clorox stock in a transaction on Tuesday, November 6th. The shares were sold at an average price of $157.39, for a total value of $8,531,324.95. Following the completion of the sale, the chief operating officer now owns 37,044 shares of the company’s stock, valued at approximately $5,830,355.16. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, SVP Diego J. Barral sold 12,880 shares of Clorox stock in a transaction on Tuesday, November 6th. The shares were sold at an average price of $157.98, for a total transaction of $2,034,782.40. Following the completion of the sale, the senior vice president now directly owns 18,603 shares of the company’s stock, valued at approximately $2,938,901.94. The disclosure for this sale can be found here. In the last ninety days, insiders sold 96,353 shares of company stock valued at $14,762,793. 1.40% of the stock is owned by company insiders.

CLX has been the topic of several research analyst reports. Zacks Investment Research upgraded shares of Clorox from a “hold” rating to a “buy” rating and set a $171.00 price objective on the stock in a research report on Wednesday, October 3rd. Deutsche Bank cut shares of Clorox from a “hold” rating to a “sell” rating and set a $123.00 price target on the stock. in a report on Wednesday, October 10th. Argus upgraded shares of Clorox from a “hold” rating to a “buy” rating and set a $175.00 price target on the stock in a report on Tuesday, September 25th. UBS Group initiated coverage on shares of Clorox in a report on Wednesday, July 18th. They set a “sell” rating and a $110.00 price target on the stock. Finally, Wells Fargo & Co boosted their price target on shares of Clorox from $135.00 to $145.00 and gave the company a “market perform” rating in a report on Wednesday, October 17th. Four analysts have rated the stock with a sell rating, eight have given a hold rating and three have issued a buy rating to the stock. Clorox has a consensus rating of “Hold” and a consensus target price of $141.64.

COPYRIGHT VIOLATION WARNING: “Clorox Co (CLX) Shares Bought by Cornerstone Wealth Management LLC” was first reported by Daily Political and is owned by of Daily Political. If you are accessing this story on another site, it was illegally copied and reposted in violation of United States & international copyright and trademark laws. The original version of this story can be accessed at https://www.dailypolitical.com/2018/11/11/clorox-co-clx-shares-bought-by-cornerstone-wealth-management-llc.html.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning, disinfecting, and food service products under the Clorox, Dispatch, HealthLink, Clorox Healthcare, Hidden Valley, KC Masterpiece, and Soy Vay brands.

Further Reading: Google Finance Portfolio Tips and Tricks

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Co (NYSE:CLX).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.